| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/13/2011 | CN1788738B Medicinal preparation containing volatile oil and preparing method thereof |
| 07/13/2011 | CN102123737A Conjugates for the administration of biologically active compounds |
| 07/13/2011 | CN102123733A Composition comprising a complexed (m)RNA and a naked (m)RNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| 07/13/2011 | CN102123730A Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 07/13/2011 | CN102123702A Composition and method of preparation of release systems for constant (zero-order) release of active agents |
| 07/13/2011 | CN102123699A Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 07/13/2011 | CN102123698A Carrier nanoparticles and related compositions, methods and systems |
| 07/13/2011 | CN102123613A Flavor improving agent |
| 07/13/2011 | CN102120855A pH-responsive three-dimensional ordered macroporous controlled-release material |
| 07/13/2011 | CN102120854A Temperature-responsive three-dimensional ordered macroporous controlled-release material |
| 07/13/2011 | CN102120823A Synthesis of water soluble zein and application thereof in pharmaceutical preparation |
| 07/13/2011 | CN102120781A Preparation and application of novel oral insulin nanoparticles |
| 07/13/2011 | CN102120773A Dual specificity antibodies and methods of making and using |
| 07/13/2011 | CN102120756A Taxol-based small molecule hydrogel-nanosphere transmission system and preparation method thereof |
| 07/13/2011 | CN102120755A Brown adipose tissue targeted polypeptide and applications thereof |
| 07/13/2011 | CN102120169A Sodium iron chlorophyllin-chitosan/sodium alginate microcapsules and preparation method thereof |
| 07/13/2011 | CN102120045A Probiotics-containing female hygienic product as well as preparation method and application thereof |
| 07/13/2011 | CN102120036A Nano micelle of biodegradable macromolecular-bonding Pt(IV) anti-cancer medicament and preparation method thereof |
| 07/13/2011 | CN102120035A Novel targeted medicament for treating metabolic syndrome by targeting at white adipose tissues |
| 07/13/2011 | CN102120034A Novel targeted medicament targeted to brown adipose tissues for treating obesity |
| 07/13/2011 | CN102120033A Collagen sustained-release carrier material for promoting repair of various traumas in oral and maxillofacial regions and method for preparing same |
| 07/13/2011 | CN102120032A Water-soluble substrate suitable for preparing water-soluble preparations of bleomycin and homologues thereof |
| 07/13/2011 | CN102120029A Preparation method of alginate microparticles capable of inducing tumor immune response |
| 07/13/2011 | CN102120027A Composition of ciclosporin A and amphipathic chitosan derivatives and preparation thereof |
| 07/13/2011 | CN102120026A 21(S) argatroban intravenous injection with alcohol as solubilizer |
| 07/13/2011 | CN102120016A Method for preparing Sichuan fritillary bulb and fructus momordicae cough relieving tablets |
| 07/13/2011 | CN102120005A Traditional Chinese medicine for soothing liver, regulating qi and promoting bile flow and preparation method and quality standard thereof |
| 07/13/2011 | CN102119996A Preparation method of sugarless fritillaria cirrhosa-fructus momordicae granules for relieving cough |
| 07/13/2011 | CN102119992A Pharmaceutical preparation prepared from fresh motherwort and fresh aloe and preparation method thereof |
| 07/13/2011 | CN102119944A Dammarane type glycoside composition particles |
| 07/13/2011 | CN102119932A Ophthalmic composition for silicone hydrogel contact lenses |
| 07/13/2011 | CN102119931A Novel metformin hydrochloride slow-releasing tablet and preparation method thereof |
| 07/13/2011 | CN102119930A Olmesartan medoxomil tablets and preparation method thereof |
| 07/13/2011 | CN102119927A Enteric-coated pellet preparation of proton pump inhibitor and preparation method thereof |
| 07/13/2011 | CN102119925A Protein nano particle with tissue factor targeting property and preparation method and application thereof |
| 07/13/2011 | CN102119924A Monodisperse nano aztreonam liposome preparation and preparation method thereof |
| 07/13/2011 | CN102119923A Antibiotic oil-water double suspension type injection emulsion for livestock and preparation method thereof |
| 07/13/2011 | CN102119922A 21(S) Argatroban intravenous injection taking acid as solubilizer |
| 07/13/2011 | CN102119921A Aivlosin injection for swine and preparation method thereof |
| 07/13/2011 | CN102119920A Edaravone injection and preparation method thereof |
| 07/13/2011 | CN102119919A Preparation method of valnemulin oily injection |
| 07/13/2011 | CN102119918A Medicinal sustained-release preparation for treating osteomyelitis and preparation method and application thereof |
| 07/13/2011 | CN102119917A Preparation method of recombinant human endostatin temperature sensitive gel |
| 07/13/2011 | CN102119916A Liquid oxygen in-situ forming gel and preparation method and application thereof |
| 07/13/2011 | CN101721378B Method for preparing cefmenoxime hydrochloride freeze-dried powder injection |
| 07/13/2011 | CN101716142B Nimesulide injection for livestock and preparation method thereof |
| 07/13/2011 | CN101623428B Lung-clearing oral liquid for treating upper respiratory tract infection |
| 07/13/2011 | CN101569749B preparation method of dextran-hemoglobin conjugate as potential blood substitute |
| 07/13/2011 | CN101496813B Applicance of combination in drug coating of preparing anti-hyperblastosis (vascular restenosis) support |
| 07/13/2011 | CN101313938B Magnolia flower volatile oil spray for nose |
| 07/13/2011 | CN101301267B Bilobalide B injection and preparation thereof |
| 07/13/2011 | CN101190213B Docetaxel injection and preparation method thereof |
| 07/13/2011 | CN101084950B Traditional Chinese medicinal composition containing red sage root, notoginseng, radix astragali and musk or muscone and preparation |
| 07/13/2011 | CN101076344B Multi-purpose bio-material composition |
| 07/12/2011 | US7977506 Amino acid for delivering active materials; bioavailability |
| 07/12/2011 | US7977465 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 07/12/2011 | US7977464 Antibody molecules specific to human tumour necrosis factor alpha |
| 07/12/2011 | US7977427 Method involving 1-benzotriazolyl carbonate esters of polymers |
| 07/12/2011 | US7977373 Prodrugs of ion channel modulating compounds and uses thereof |
| 07/12/2011 | US7977369 Via 3-hydroxymethyl-5-aziridinyl-1-1-methyl-2-(1H-indole-4,7-dione )propenol |
| 07/12/2011 | US7977317 Compositions and methods for modulating blood-brain barrier transport |
| 07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
| 07/12/2011 | US7977045 Aqueous-based pharmaceutical composition |
| 07/12/2011 | US7976870 using a sustained release oral dosage form of a therapeutically effective amount of the drug such as minocycline hydrochloride incorporated in a matrix of biocompatible, hydrophilic polymer of specified swelling properties and erosion rate |
| 07/12/2011 | US7976869 Fenofibrate tablets |
| 07/12/2011 | US7976865 Medical tape preparation |
| 07/12/2011 | US7976855 Metal ion modified high surface area materials for odor removal and control |
| 07/12/2011 | US7976847 Congestive heart failure; antiischemic agents; administering calcitonin gene related peptide in thermoplastic biocompatible polymer; controlled release or maintenance therapy |
| 07/12/2011 | US7976834 For example, glycerol initiated multiarm polyethylene glycol modified with a polypeptide and then conjugated to a drug such as 5-fluorouracil; high drug-carrying capability; useful for hydrophilic and charge-bearing drugs as well |
| 07/12/2011 | CA2581156C Stabilized leukotriene b4 (ltb4) agent pharmaceutical formulation |
| 07/12/2011 | CA2563816C New hydroxapatite calcium phosphates, their method of preparation and their applications |
| 07/12/2011 | CA2526957C Long lasting insulin derivatives and methods thereof |
| 07/12/2011 | CA2497167C Modified saccharides, conjugates thereof, and their manufacture |
| 07/12/2011 | CA2495541C Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 07/12/2011 | CA2493881C Rapidly soluble film-shaped preparation |
| 07/12/2011 | CA2483097C Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 07/12/2011 | CA2481268C Medicaments comprising steroids and a novel anticholinergic |
| 07/12/2011 | CA2475704C Colonic release formulations of prednisolone sodium metasulphobenzoate coated with amylose, ethyl cellulose and dibutyl sebacate |
| 07/12/2011 | CA2472967C Film-shaped or wafer-shaped pharmaceutical preparation with masked taste |
| 07/12/2011 | CA2463616C Affinity enhancement agents |
| 07/12/2011 | CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide |
| 07/12/2011 | CA2457528C Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) |
| 07/12/2011 | CA2454389C Solid composition containing bacillus-type non-pathogenic bacterial spores |
| 07/12/2011 | CA2441744C Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 07/12/2011 | CA2421575C Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 07/12/2011 | CA2417858C Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 07/12/2011 | CA2408956C Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 07/12/2011 | CA2406570C Dermal compositions containing coenzyme q as the active ingredient |
| 07/12/2011 | CA2397347C Factor vii or viia-like molecules |
| 07/12/2011 | CA2393200C Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 07/12/2011 | CA2373972C Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 07/12/2011 | CA2362927C Novel albumin-free factor viii formulations |
| 07/12/2011 | CA2352286C Intracellular targeted delivery of compounds by 70 kd heat shock protein |
| 07/07/2011 | WO2011082231A1 Compositions and methods for promoting epithelialization and wound closure |
| 07/07/2011 | WO2011081672A1 Low toxicity topical active agent delivery system |
| 07/07/2011 | WO2011081625A1 Melt extruded thin strips containing coated pharmaceutical actives |
| 07/07/2011 | WO2011081556A1 Composition containing 6-decaprenyl-2,3-dimethoxy-5-methyl-1,4 -benzoquinone for parenteral delivery and method for producing same |
| 07/07/2011 | WO2011081443A2 Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof |
| 07/07/2011 | WO2011081406A2 Macromolecule for delivering protein, polypeptide or peptide drugs and a production method for the same, and a slow release composition for protein, polypeptide or peptide drugs and a production method for the same |
| 07/07/2011 | WO2011081253A1 Injectable porous microparticle filler system |